These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12632030)

  • 1. Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia.
    Chuansumrit A; Suwannuraks M; Sri-Udomporn N; Pongtanakul B; Worapongpaiboon S
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):187-90. PubMed ID: 12632030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia.
    Yilmaz BT; Alioglu B; Ozyurek E; Akay HT; Mercan S; Ozbek N
    Pediatr Cardiol; 2005; 26(6):843-5. PubMed ID: 15690232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of rFVIIa in 4 children with Glanzmann thrombasthenia.
    Valentino LA
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):653-8. PubMed ID: 17023825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia.
    Poon MC; Demers C; Jobin F; Wu JW
    Blood; 1999 Dec; 94(11):3951-3. PubMed ID: 10572113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant activated factor VII combined with desmopressin in preventing bleeding from dental extraction in a patient with Glanzmann's thrombasthenia.
    Lombardo VT; Sottilotta G
    Clin Appl Thromb Hemost; 2006 Jan; 12(1):115-6. PubMed ID: 16444446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
    Hennewig U; Laws HJ; Eisert S; Göbel U
    Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
    Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Concentrations of Recombinant Factor VIIa May Improve the Impaired Thrombin Generation of Glanzmann Thrombasthenia Patients.
    Levy-Mendelovich S; Levy T; Budnik I; Barg AA; Rosenberg N; Seligsohn U; Kenet G; Livnat T
    Thromb Haemost; 2019 Jan; 119(1):117-127. PubMed ID: 30597506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.
    Poon MC; d'Oiron R; Hann I; Négrier C; de Lumley L; Thomas A; Karafoulidou A; Demers C; Street A; Huth-Kühne A; Petrini P; Fressinaud E; Morfini M; Tengborn L; Marquès-Verdier A; Musso R; Devecioglu O; Houston DS; Lethagen S; Van Geet C; von Depka M; Berger C; Beurrier P; Britton HA; Gerrits W; Guthner C; Kuhle S; Lorenzo JJ; Makris PE; Nohe N; Paugy P; Pautard B; Torchet MF; Trillot N; Vicariot M; Wilde J; Winter M; Chambost H; Ingerslev J; Peters M; Strauss G
    Semin Hematol; 2001 Oct; 38(4 Suppl 12):21-5. PubMed ID: 11735106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey.
    Poon MC; D'Oiron R; Von Depka M; Khair K; Négrier C; Karafoulidou A; Huth-Kuehne A; Morfini M;
    J Thromb Haemost; 2004 Jul; 2(7):1096-103. PubMed ID: 15219192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor.
    Laguna P; Klukowska A
    Haemophilia; 2005 Jan; 11(1):2-4. PubMed ID: 15660981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights Into the Treatment of Glanzmann Thrombasthenia.
    Poon MC; Di Minno G; d'Oiron R; Zotz R
    Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy.
    Erduran E; Aksoy A; Zaman D
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):215-7. PubMed ID: 19657319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia.
    Andiç N; Oğuz N; Gündüz E; Kiraz Bulduk T; Üsküdar Teke H
    Blood Coagul Fibrinolysis; 2021 Jul; 32(5):349-351. PubMed ID: 33878047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.
    Di Minno G; Zotz RB; d'Oiron R; Bindslev N; Di Minno MN; Poon MC;
    Haematologica; 2015 Aug; 100(8):1031-7. PubMed ID: 26001793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa?
    Laurian Y
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():37-40. PubMed ID: 12214146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia.
    He S; Ekman GJ; Hedner U
    J Thromb Haemost; 2005 Feb; 3(2):272-9. PubMed ID: 15670032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.
    Poon MC; d'Oiron R; Zotz RB; Bindslev N; Di Minno MN; Di Minno G;
    Haematologica; 2015 Aug; 100(8):1038-44. PubMed ID: 26001792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia.
    Balci YI; Karabulut A; Kabukcu S; Sari I; Keskin A
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):320-2. PubMed ID: 20460355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders.
    Croom KF; McCormack PL
    BioDrugs; 2008; 22(2):121-36. PubMed ID: 18345709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.